SlideShare a Scribd company logo
Genetic basis of
epilepsy
By Ahmed Abdelhady
What role do genetics play in epilepsy?
• Genetics play a part in many types of epilepsy. It seems likely that the seizure threshold, for
example, is partly determined by genetics. Epilepsy often runs in families:
• • If a parent has idiopathic epilepsy, there is about a 9% to 12% chance that the child will also have
epilepsy.
• • if a child has epilepsy, his brothers and sisters do have a higher risk of having epilepsy.
• • If one twin has idiopathic epilepsy, the identical twin is very likely to have it as well.
• • For some reason, children of women with epilepsy have a higher chance of having epilepsy than
children of men with epilepsy.
• Family studies have shown that some epilepsy syndromes are completely determined by genetics,
and genes are a major factor in other syndromes. Some inherited metabolic conditions also raise the
likelihood of having seizures, as do some chromosomal disorders.
What types of genetic disorders are there?
There are five types of genetic disorders:
• Single gene or Mendelian disorders (Monogenic). A single mutated gene is
sufficient to cause the phenotype. Single gene disorders are typically described
as inherited in families, since they are passed from one generation to the next.
• Multifactorial or complex disorders. These are related to mutations in a
number of genes (polygenic), often coupled with an environmental influence.
Environmental factors include things like alcohol or drug use, maternal
infections, and exposure to hazardous materials. These disorders tend to run in
families, although a pattern of inheritance is often difficult to identify.
• Mitochondrial disorders. These disorders result from mutations in DNA
found outside the cell nucleus in mitochondria. Mitochondria are structures that make
energy for the cells. If there is a mitochondrial gene mutation, energy production is
affected. The DNA in mitochondria is inherited only from the mother.
• Chromosomal disorders. These disorders result when entire chromosomes or
parts of chromosomes are missing or changed. Chromosomal disorders usually occur
spontaneously, however, on rare occasions they are inherited.
• Epigenetic disorders. These are disorders related to changes in the activity of
genes, rather than a mutation in the structure of the DNA
SINGLE GENE MUTATION
(MONOGENIC)
Classification of Single gene mutation
(monogenic)
A-Ion channels implicated in human epilepsy
I. Autosomal dominant inheritance
1. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
2. Benign familial neonatal convulsion (BFNC)
3. Generalized epilepsy with febrile seizures plus (GEFS+)
4. Juvenile myoclonic epilepsy (JME)
5. Autosomal dominant idiopathic generalized epilepsy
Classification of Single gene mutation
(monogenic)
II. Sporadic
1. Severe myoclonic epilepsy of infancy
III.Other ion channel gene implicated in epilepsy (mutation identified
in small number of patients, so role in epilepsy less clear)
1. Episodic ataxia type 1 and type 2
Classification of Single gene mutation
(monogenic)
• B- Single Non ion channel gene mutation implicated in epilepsy
1. Progressive myoclonic epilepsy (PME)
2. Autosomal dominant partial epilepsy with auditory features (ADPEAF)
• C- single gene mutation with high risk of developing epilepsy
Ion channels implicated in human epilepsy (AD)
• 1-Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
• Feature:- characterized by childhood onset of clusters of sleep-related
seizures with predominant motor and dystonic features.
• Gene , locus and protein
CHRNA4 20q13 Ach receptor α4 subunit
CGRNB2 1q21 Ach receptor β2 subunit
The neuronal nicotinic acetylcholine receptors (nAChRs) (CHRNA4/CHRNB2) are pentamers, with each subunit containing four transmembrane
domains. At least ten nAChR subunits, which can assemble into heteromeric (α2–α6, β2–β4) or homomeric receptors ((α 7, (α 9), are expressed in the
human brain. The binding of two agonist molecules is required for channel opening. The channel itself shows little selectivity among monovalent cations
Ion channels implicated in human epilepsy (AD)
• 2- Benign familial neonatal convulsion (BFNC)
• Feature:- is a rare, highly penetrant, autosomal dominant disorder with short-lasting
multifocal or generalized seizures beginning between a few days of life and three
months of age. A few patients will manifest isolated seizures later in life.
• locus , Gene , and protein
• 20q13 KCNQ2 M-current potassium channel
• 8q24 KCNQ3 M-current potassium channel
Voltage-gated potassium channels (KCNQ2/KCNQ3) are tetramers made up from homologous subunits. Each subunit contains six transmembrane
domains. The fourth transmembrane domain carries several positively charged amino acids, which cause a conformational change on membrane
depolarization. The linker between transmembrane domains 5 and 6 contains the selectivity filter that lines the ion pore
Ion channels implicated in human epilepsy (AD)
• 3-Generalized epilepsy with febrile seizures plus (GEFS+)
• Feature:- GEFS+ encompasses a spectrum of childhood-onset epilepsy phenotypes including FS and
FS+ (when afebrile seizures occur and/or FS continue past age six years). Other less-common
phenotypes are FS+ with absence, myoclonic or atonic seizures, partial epilepsies, myoclonic astatic
epilepsy (MAE) and severe myoclonic epilepsy in infancy
• locus , Gene , and protein
• 2q24 SCN1A Voltage-gated sodium channel α1 subunit
19q13 SCN1B Voltage-gated sodium channel β1 subunit
2q23 SCN2A Voltage-gated sodium channel α2 subunit
5q31 GABRG2 GABAA receptor subunit (discuss in JME)
Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the
structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the
gating kinetics of the channel.
Ion channels implicated in human epilepsy (AD)
• 4-Juvenile myoclonic epilepsy (JME)
• Feature:- Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years
old. People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon
awakening or shortly afterward. Half of patients with this condition have relatives with
epilepsy. The genetic basis of this syndrome is complex and the mechanism of transmission is
unclear.
• locus , Gene , and protein
• 5q34-q35 GABRA1 GABA A receptor a1 subunit
The GABAA (γ-aminobutyric acid, subtype A) receptors (GABRG2/GABRA1) are ligand-gated ion channels that probably evolved from the same
ancient genes as the nAChRs, with whom they share several features, such as four transmembrane domains per subunit and a pentameric structure.
GABAA receptors are selective for small anions and allow both chloride and bicarbonate to permeate
Ion channels implicated in human epilepsy (AD)
5- autosomal dominant idiopathic generalized epilepsy
• locus , Gene , and protein
• 3q26 CLCN2 Chloride channels
Voltage-gated chloride channels of the CLCN type comprise a gene family with nine
mammalian members. They build homodimeric proteins, which probably contain two
separate pores. CLCN channels conduct chloride ions across cell membranes, governing the
electrical activity of cells.
Ion channels implicated in human epilepsy (sporadic)
1. Severe myoclonic epilepsy of infancy (Dravet’s syndrome)
• Feature:- Severe myoclonic epilepsy of infancy (SMEI) is an epileptic encephalopathy
beginning in infancy with prolonged clonic febrile and afebrile seizures and is
subsequently associated in most children with myoclonic, atypical absence and sometimes
focal seizures Sporadic SMEI has been associated with de novo SCN1A mutations in
30% of patients
• Gene , locus and protein
SCN1A 2q24 Sodium channel subunit
Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the
structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the
gating kinetics of the channel.
Other ion channel gene implicated in epilepsy (mutation identified in small number of
patients, so role in epilepsy less clear)
1- Episodic ataxia type 1 and 2 (EA1,2)
Gene , locus and protein
In EA1 KCNA1 12p13 Potassium channel subunit
In EA2 CACNA1A 19p13 Calcium channel subunit
Single Non ion channel gene mutation
implicated in epilepsy
1-Progressive myoclonus epilepsies (PMEs)
• The progressive myoclonus epilepsies (PMEs) are a group of rare disorders in which there is
progressive neurological deterioration together with myoclonus (twitching) and epilepsy. Several
PMEs have autosomal recessive inheritance, including:
A- AD as
1. dentatorubral-pallidoluysian atrophy (DRPLA),
B- AR as
1. Unverricht-Lundborg disease
2. Sialidosis or cherry-red spot myoclonus
3. Lafora’s disease
4. Neuronal ceroid lipofuscinosis (NCL or Batten’s disease)
phenotype Mood of
inheritance
feature gene locus protein
dentatorubral-
pallidoluysian
atrophy
AD appears before age 30; affected
people have muscle twitches,
epilepsy, dementia, ataxia , and
choreoathetosis
CAG expansion in a gene on
12p13.31
Unverricht-
Lundborg disease
AR Usually presents in childhood
with stimulus sensitive and
spontaneous myoclonus, tonic-
clonic seizures, ataxia, and mild
cognitive decline
cystatin B
gene
21q22.3 protease
inhibitor
Sialidosis or cherry-
red spot myoclonus
AR Storage disese the sialidase gene on 6p21.3.
phenotype Mood of
inheritance
feature gene locus protein
Lafora’s disease AR Myoclonic epilepsy with onset in
the second decade, associated
with visual hallucinations and
cognitive decline. The
characteristic carbohydrate
accumulations (Lafora bodies)
EPM2A/
EPM2B
6q24 Laforin is
a tyrosine
phosphata
se
Neuronal ceroid
lipofuscinosis
(NCL or Batten’s
disease)
AR associated with early visual
impairment, cognitive decline,
and spasticity
1-palmitoyl-protein thioesterase gene
(1p32), causing either infantile or
juvenile-onset NCL
2- the tripeptidyl peptidase 1 gene
(11q15) and associated with late infantile
onset NCL
3- CLN3 gene on 16p associated with a
juvenile-onset form
Single Non ion channel gene mutation
implicated in epilepsy
2-Autosomal dominant partial epilepsy with auditory features (ADPEAF)
• Feature:- familial temporal lobe epilepsy (FTLE) includes mesial and lateral forms. The lateral
FTLE [autosomal dominant partial epilepsy with auditory features (ADPEAF)] begins in
childhood–adolescence with auditory hallucinations, alone or with other sensory (olfactory,
vertiginous, visual) symptoms. Mesial FTLE has childhood onset and seizures have mesial temporal
lobe auras, including de ´ja ` vu, perceptual changes or autonomic phenomena No loci have been
found.
• Gene , locus and protein
ADPEAF 10q24 LGI1 Leucine-rich glioma inactivated 1
Functional inactivation of one allele led to ADPEAF, whereas silencing of both alleles was observed
in several high-grade gliomas.
LGI1 is secreted from the presynapse and binds to postsynaptic ADAM22. Binding to ADAM22 results in altered
intracellular signalling in the postsynapse that decreases excitability, probably through subunit changes in
postsynaptic glutamate receptors. Mutations in LGI resulting in lack of ADAM22-mediated signalling therefore
result in a net increase in excitability.
Epitempin repeat in epilepsy-associated genes. The proteins encoded by both LGI1, the gene involved in autosomal
dominant lateral temporal lobe epilepsy, and the MASS1/VLGR1 gene, which is mutated in the Frings mouse model for
audiogenic seizures and in one family with febrile seizures, share the epitempin repeat. The MASS1/VLGR1 protein — one
of the largest membrane proteins and a member of the superfamily of seven-helix G-protein coupled receptors — contains
six complete and one degenerate copy of the epitempin repeat. MASS1/VLGR1 is expressed in the developing nervous
system rather than in the adult brain. Its overall structure shows homologies to large G protein coupled receptors from the
flamingo family, the latrophilins and the brain angiogenesis inhibitors. These receptors are mainly involved in neuronal
development. Furthermore, the leucine-rich repeat (LRR) domain subtype present in the LGI1 protein is also found in Slit, a
neurogenic protein involved in axonal guidance. It is therefore tempting to speculate that both MASS1/VLGR1 and LGI1
cause epilepsy by interference with normal brain development. aa, amino acid residues; TM, transmembrane domain
Other single gene disorders that can manifest
as epilepsy
• Tuberous sclerosis
• Tuberous sclerosis (TS) is a frequent cause of malignant childhood epilepsy, in particular
West syndrome (hypsarrhythmia, mental retardation, and infantile spasms). Approximately
half of patients with TS are familial cases, and the other half are sporadic. TS is caused by
dominant mutations of one or other of two tumour suppressor genes (TSC1 and TSC2
located on 9q34 and 16p13.3, respectively) Approximately 80% of people with tuberous
sclerosis develop epilepsy
• Neurofibromatosis 1 (NF-1)
• Approximately 3% to 13% of people with NF-1 develop epilepsy, although with a far better
prognosis than TS.
.
Fragile X syndrome
Fragile X syndrome is caused by a gene mutation on the X chromosome. It causes mild
to severe intellectual disability, and approximately 20% to 40% of people with the
condition will also develop epilepsy. If a father has fragile X syndrome, he will pass a
milder form of the disorder to his daughters but will not pass it to his sons. If a mother
has fragile X syndrome, her children have a 50% chance of inheriting it. The gene is
often passed down in a milder form, so that families may be unaware that they carry it.
Rett syndrome
Rett syndrome is caused, in most cases, by a newly discovered mutation on the X
chromosome. In a few families, the syndrome is inherited in an X-linked dominant
pattern. It was initially believed that Rett syndrome affects only girls; however, it has
recently been found to occur rarely in boys as well. The disorder usually develops
between one and two years of age. Children with the disorder have epilepsy in 70% to
80% of cases, together with other problems such as constant hand-wringing, difficulty
walking, developmental disability and autism.
Acute intermittent porphyria
Acute intermittent porphyria is a rare disease caused by a gene mutation in the HMBS
gene on chromosome 11, which controls a step in the production of hemoglobin. The
symptoms of the condition consist of severe attacks of abdominal pain, vomiting,
digestive problems, and seizures. The attacks are triggered by factors such as certain
drugs, smoking, dieting, other illnesses, and stress.
Leukodystrophies
Leukodystrophies are disorders affecting the production or maintenance of
the fatty covering of nerves. As a result, signals travel more slowly than
normal through the nervous system. This disrupts the functioning of the
nervous system, which can sometimes include seizures. Leukodystrophies
can be caused by mutations in many different genes; their inheritance
pattern depends on which gene is affected. In some cases, the mutation
arises spontaneously. More than 30 leukodystrophies have been identified.
Some specific leukodystrophies are Alexander disease, Canavan disease,
and Krabbe disease.
inherited metabolic conditions
A number of inherited metabolic conditions may cause seizures, including:
• aminoacidopathies such as phenylketonuria (PKU) and maple syrup urine
disease
• galactosemia
• lysosomal lipid storage diseases such as Tay-Sachs disease
• peroxisomal disorders
• pseudohypoparathyroidism
• pyridoxine dependency
Multifactorial disorders
Multifactorial disorders
• A number of epilepsy syndromes are thought to be multifactorial or complex
disorders, in which genetic and environmental factors both seem to play a part.
• Among epilepsies with complex inheritance, IGEs seem very suitable for genetic
studies because they are common. BUT the unknown mode of inheritance, the
heterogeneity of the epilepsy phenotypes, the uncertainty of the genetic overlapping
of IGE sub-syndromes and the lack of large families are major obstacles to the
study of the genetic architecture of IGE
Myoclonic-astatic epilepsy
Myoclonic-astatic epilepsy usually appears between two and five years of age, with a variety
of seizure types. The relatives of affected children often have other forms of epilepsy or
febrile seizures, suggesting a strong genetic component. It is possible that several different
genes are involved, as well as other modifying factors.
Benign epilepsy of childhood with centrotemporal spikes (BECTS)
Benign epilepsy of childhood with centrotemporal spikes (BECTS), also known as benign
rolandic epilepsy, is one of the most common childhood epilepsy syndromes. It usually
begins between ages five and 10 years and disappears in adolescence.
Benign myoclonic epilepsy of infancy
Benign myoclonic epilepsy of infancy is a rare condition that usually affects children
between six months and three years old. Children with the syndrome have brief
myoclonicseizures that are usually easy to control with medication. In about 30% of cases,
other family members also have some form of epilepsy or febrile convulsions.
Juvenile myoclonic epilepsy
Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years old.
People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon
awakening or shortly afterward. Half of patients with this condition have relatives with
epilepsy. The genetic basis of this syndrome is complex and the mechanism of
transmission is unclear. It is possible that several different genes are responsible.
Childhood absence epilepsy
Childhood absence epilepsy begins between four and 10 years old, and involves severe
and frequent absence seizures. In up to 44% of cases, other family members also have
epilepsy. Some researchers have found links to chromosome 1 or chromosome 8.
However, it seems likely that other factors besides genetics are involved.
Juvenile absence epilepsy
Juvenile absence epilepsy is similar to childhood absence epilepsy, but usually begins later
in life, between 10 and 17 years old. Some children with this syndrome have family
members with epilepsy.
Mitochondrial disorders
Mitochondrial disorders
• Myoclonus epilepsy and ragged-red fibres (MERRF)
Myoclonus epilepsy and ragged-red fibres (MERRF) is a progressive myoclonus
epilepsy that is caused by missense mutations in the mitochondrial gene coding
for lysine tRNA. People with this syndrome manifest it in a wide variety of
ways; some are unaffected, some develop epilepsy later in life, and others
develop severe, progressive epilepsy with dementia as children. The mutation is
passed from mother to child.
Chromosomal disorders
Chromosomal disorders
1- Down syndrome
Down syndrome is caused by an additional copy of chromosome 21. This means that
instead of the normal pair of chromosomes, there are 3 copies. This is called a
trisomy. Down syndrome is also referred to as Trisomy 21. A trisomy is caused by an
error that occurs during cell division. Approximately 2% to 15% of people with Down
syndrome develop epilepsy.
• Other trisomies
Other trisomies that can result in epilepsy in 20% to 25% of cases are trisomy 18
(Edwards syndrome), trisomy 13 (Patau syndrome), and trisomy 22.
2- Wolf-Hirschhorn syndrome
Wolf-Hirschhorn syndrome occurs when part of chromosome 4 is deleted.
About 70% of people with this condition have epilepsy.
3- Angelman syndrome
Angelman syndrome is caused by a deletion on one arm of the copy of chromosome 15 that came from the
person’s mother. More than 80% of people with this condition develop seizures, usually by age three.
4- Ring chromosome abnormalities
Ring chromosome abnormalities are rare disorders that occur when both ends of
a chromosome are damaged and the chromosome reforms in a ring shape. Ring
chromosome abnormalities, including ring chromosomes 6, 9, 14, 15, and 20,
account for 2% to 3% of cases of epilepsy, although not all people with these
conditions have seizures.
Genetic basis of epilepsy

More Related Content

What's hot

Pediatric epilepsy syndromes
Pediatric epilepsy syndromesPediatric epilepsy syndromes
Pediatric epilepsy syndromesNeurologyKota
 
Temporal lobe epilepsy
Temporal lobe epilepsyTemporal lobe epilepsy
Temporal lobe epilepsy
Siva Pesala
 
Approach to Leukodystrophy
Approach to Leukodystrophy Approach to Leukodystrophy
Approach to Leukodystrophy
NeurologyKota
 
Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Prashant Makhija
 
Pediatric EEG - by Dr.Rajesh Ramachandran Nair
Pediatric EEG - by Dr.Rajesh Ramachandran Nair Pediatric EEG - by Dr.Rajesh Ramachandran Nair
Pediatric EEG - by Dr.Rajesh Ramachandran Nair
Dr Padmesh Vadakepat
 
Autoimmune encephalitis ppt
Autoimmune encephalitis pptAutoimmune encephalitis ppt
Autoimmune encephalitis ppt
Sachin Adukia
 
Abnormal focal eeg patterns
Abnormal focal eeg patternsAbnormal focal eeg patterns
Abnormal focal eeg patterns
Pramod Krishnan
 
Approach to parkinsonism
Approach to parkinsonismApproach to parkinsonism
Approach to parkinsonism
NeurologyKota
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptx
Pramod Krishnan
 
Landau-Kleffner syndrome (LKS)
Landau-Kleffner syndrome (LKS)Landau-Kleffner syndrome (LKS)
Landau-Kleffner syndrome (LKS)
Azad Haleem
 
Approach to ataxia
Approach to ataxiaApproach to ataxia
Approach to ataxia
Divya Shilpa
 
Sub acute sclerosing panencephalitis
Sub acute sclerosing panencephalitisSub acute sclerosing panencephalitis
Sub acute sclerosing panencephalitisNeurologyKota
 
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
Ade Wijaya
 
EEG in idiopathic generalised epilepsies
EEG in idiopathic generalised epilepsiesEEG in idiopathic generalised epilepsies
EEG in idiopathic generalised epilepsies
NeurologyKota
 
Nmosd & mog
Nmosd & mogNmosd & mog
Nmosd & mog
NeurologyKota
 
Neuro degenerative disease, pediatric neurologist, dr amit vatkar
Neuro  degenerative disease, pediatric neurologist, dr amit vatkarNeuro  degenerative disease, pediatric neurologist, dr amit vatkar
Neuro degenerative disease, pediatric neurologist, dr amit vatkar
Dr Amit Vatkar
 
Presurgical Evaluation Of Intractable Epilepsy
Presurgical Evaluation Of Intractable EpilepsyPresurgical Evaluation Of Intractable Epilepsy
Presurgical Evaluation Of Intractable Epilepsy
NeurologyKota
 
Generalised periodic epileptiform discharges
Generalised periodic epileptiform dischargesGeneralised periodic epileptiform discharges
Generalised periodic epileptiform discharges
Pramod Krishnan
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
NeurologyKota
 
Anti-IgLON5 Disease.pptx
Anti-IgLON5 Disease.pptxAnti-IgLON5 Disease.pptx
Anti-IgLON5 Disease.pptx
Ade Wijaya
 

What's hot (20)

Pediatric epilepsy syndromes
Pediatric epilepsy syndromesPediatric epilepsy syndromes
Pediatric epilepsy syndromes
 
Temporal lobe epilepsy
Temporal lobe epilepsyTemporal lobe epilepsy
Temporal lobe epilepsy
 
Approach to Leukodystrophy
Approach to Leukodystrophy Approach to Leukodystrophy
Approach to Leukodystrophy
 
Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)
 
Pediatric EEG - by Dr.Rajesh Ramachandran Nair
Pediatric EEG - by Dr.Rajesh Ramachandran Nair Pediatric EEG - by Dr.Rajesh Ramachandran Nair
Pediatric EEG - by Dr.Rajesh Ramachandran Nair
 
Autoimmune encephalitis ppt
Autoimmune encephalitis pptAutoimmune encephalitis ppt
Autoimmune encephalitis ppt
 
Abnormal focal eeg patterns
Abnormal focal eeg patternsAbnormal focal eeg patterns
Abnormal focal eeg patterns
 
Approach to parkinsonism
Approach to parkinsonismApproach to parkinsonism
Approach to parkinsonism
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptx
 
Landau-Kleffner syndrome (LKS)
Landau-Kleffner syndrome (LKS)Landau-Kleffner syndrome (LKS)
Landau-Kleffner syndrome (LKS)
 
Approach to ataxia
Approach to ataxiaApproach to ataxia
Approach to ataxia
 
Sub acute sclerosing panencephalitis
Sub acute sclerosing panencephalitisSub acute sclerosing panencephalitis
Sub acute sclerosing panencephalitis
 
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal...
 
EEG in idiopathic generalised epilepsies
EEG in idiopathic generalised epilepsiesEEG in idiopathic generalised epilepsies
EEG in idiopathic generalised epilepsies
 
Nmosd & mog
Nmosd & mogNmosd & mog
Nmosd & mog
 
Neuro degenerative disease, pediatric neurologist, dr amit vatkar
Neuro  degenerative disease, pediatric neurologist, dr amit vatkarNeuro  degenerative disease, pediatric neurologist, dr amit vatkar
Neuro degenerative disease, pediatric neurologist, dr amit vatkar
 
Presurgical Evaluation Of Intractable Epilepsy
Presurgical Evaluation Of Intractable EpilepsyPresurgical Evaluation Of Intractable Epilepsy
Presurgical Evaluation Of Intractable Epilepsy
 
Generalised periodic epileptiform discharges
Generalised periodic epileptiform dischargesGeneralised periodic epileptiform discharges
Generalised periodic epileptiform discharges
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Anti-IgLON5 Disease.pptx
Anti-IgLON5 Disease.pptxAnti-IgLON5 Disease.pptx
Anti-IgLON5 Disease.pptx
 

Similar to Genetic basis of epilepsy

Anti epileptogenesis
Anti epileptogenesisAnti epileptogenesis
Anti epileptogenesis
Amr Hassan
 
Chromosomal brekage syndrome
Chromosomal brekage syndromeChromosomal brekage syndrome
Chromosomal brekage syndrome
Reetika (jmu)
 
Channelopathies pamela
Channelopathies pamelaChannelopathies pamela
Channelopathies pamelaPamela Correia
 
Mutagens in genetic disorder
Mutagens in genetic disorderMutagens in genetic disorder
Mutagens in genetic disorder
Nimra khalid
 
Triple Nucleotide Repeat Abnormality
Triple Nucleotide Repeat AbnormalityTriple Nucleotide Repeat Abnormality
Triple Nucleotide Repeat Abnormality
Ankita Sain
 
hypokalemic periodic paralysis
hypokalemic periodic paralysishypokalemic periodic paralysis
hypokalemic periodic paralysislaxmikant joshi
 
Review Nature 399 A15
Review Nature 399 A15Review Nature 399 A15
Review Nature 399 A15MADHU.MATHEWS
 
cosa
cosacosa
cosaknpa
 
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Pasteur_Tunis
 
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptxEEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
PANFRAGGER
 
3. MEGALOBLASTIC ANEMIA- BDS.ppt
3. MEGALOBLASTIC ANEMIA- BDS.ppt3. MEGALOBLASTIC ANEMIA- BDS.ppt
3. MEGALOBLASTIC ANEMIA- BDS.ppt
DIVINEtourist
 
DISORDER OF LIPIDS METABOLISM PART 1.pptx
DISORDER OF LIPIDS METABOLISM PART 1.pptxDISORDER OF LIPIDS METABOLISM PART 1.pptx
DISORDER OF LIPIDS METABOLISM PART 1.pptx
Mkindi Mkindi
 
Overview of neonatal epilepsy syndromes.pptx
Overview of neonatal epilepsy syndromes.pptxOverview of neonatal epilepsy syndromes.pptx
Overview of neonatal epilepsy syndromes.pptx
philipolielo1
 
IEM2.pptx
IEM2.pptxIEM2.pptx
Mitochondrial genes and neurology
Mitochondrial genes and neurologyMitochondrial genes and neurology
Mitochondrial genes and neurology
NeurologyKota
 
APPROACH TO CHANNELOPATHIES.pptx
APPROACH TO CHANNELOPATHIES.pptxAPPROACH TO CHANNELOPATHIES.pptx
APPROACH TO CHANNELOPATHIES.pptx
sumeetsingh837653
 
Central nervous system 2
Central nervous system 2Central nervous system 2
Central nervous system 2
Dr. Arpit Gohel
 
the molecular, biochemical.pptx
the molecular, biochemical.pptxthe molecular, biochemical.pptx
the molecular, biochemical.pptx
drRiyan1
 
Neonatal seziure
Neonatal seziureNeonatal seziure
Neonatal seziure
asmaaabdelwakeel
 

Similar to Genetic basis of epilepsy (20)

Anti epileptogenesis
Anti epileptogenesisAnti epileptogenesis
Anti epileptogenesis
 
Chromosomal brekage syndrome
Chromosomal brekage syndromeChromosomal brekage syndrome
Chromosomal brekage syndrome
 
Channelopathies pamela
Channelopathies pamelaChannelopathies pamela
Channelopathies pamela
 
Mutagens in genetic disorder
Mutagens in genetic disorderMutagens in genetic disorder
Mutagens in genetic disorder
 
Triple Nucleotide Repeat Abnormality
Triple Nucleotide Repeat AbnormalityTriple Nucleotide Repeat Abnormality
Triple Nucleotide Repeat Abnormality
 
hypokalemic periodic paralysis
hypokalemic periodic paralysishypokalemic periodic paralysis
hypokalemic periodic paralysis
 
Review Nature 399 A15
Review Nature 399 A15Review Nature 399 A15
Review Nature 399 A15
 
cosa
cosacosa
cosa
 
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
 
Chromosomal breakage syndrome
Chromosomal breakage syndromeChromosomal breakage syndrome
Chromosomal breakage syndrome
 
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptxEEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
EEG FOR EPILEPSY AND ANTICONVULSIVANT DRUGS.pptx
 
3. MEGALOBLASTIC ANEMIA- BDS.ppt
3. MEGALOBLASTIC ANEMIA- BDS.ppt3. MEGALOBLASTIC ANEMIA- BDS.ppt
3. MEGALOBLASTIC ANEMIA- BDS.ppt
 
DISORDER OF LIPIDS METABOLISM PART 1.pptx
DISORDER OF LIPIDS METABOLISM PART 1.pptxDISORDER OF LIPIDS METABOLISM PART 1.pptx
DISORDER OF LIPIDS METABOLISM PART 1.pptx
 
Overview of neonatal epilepsy syndromes.pptx
Overview of neonatal epilepsy syndromes.pptxOverview of neonatal epilepsy syndromes.pptx
Overview of neonatal epilepsy syndromes.pptx
 
IEM2.pptx
IEM2.pptxIEM2.pptx
IEM2.pptx
 
Mitochondrial genes and neurology
Mitochondrial genes and neurologyMitochondrial genes and neurology
Mitochondrial genes and neurology
 
APPROACH TO CHANNELOPATHIES.pptx
APPROACH TO CHANNELOPATHIES.pptxAPPROACH TO CHANNELOPATHIES.pptx
APPROACH TO CHANNELOPATHIES.pptx
 
Central nervous system 2
Central nervous system 2Central nervous system 2
Central nervous system 2
 
the molecular, biochemical.pptx
the molecular, biochemical.pptxthe molecular, biochemical.pptx
the molecular, biochemical.pptx
 
Neonatal seziure
Neonatal seziureNeonatal seziure
Neonatal seziure
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 

Recently uploaded (20)

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 

Genetic basis of epilepsy

  • 2. What role do genetics play in epilepsy? • Genetics play a part in many types of epilepsy. It seems likely that the seizure threshold, for example, is partly determined by genetics. Epilepsy often runs in families: • • If a parent has idiopathic epilepsy, there is about a 9% to 12% chance that the child will also have epilepsy. • • if a child has epilepsy, his brothers and sisters do have a higher risk of having epilepsy. • • If one twin has idiopathic epilepsy, the identical twin is very likely to have it as well. • • For some reason, children of women with epilepsy have a higher chance of having epilepsy than children of men with epilepsy. • Family studies have shown that some epilepsy syndromes are completely determined by genetics, and genes are a major factor in other syndromes. Some inherited metabolic conditions also raise the likelihood of having seizures, as do some chromosomal disorders.
  • 3. What types of genetic disorders are there? There are five types of genetic disorders: • Single gene or Mendelian disorders (Monogenic). A single mutated gene is sufficient to cause the phenotype. Single gene disorders are typically described as inherited in families, since they are passed from one generation to the next. • Multifactorial or complex disorders. These are related to mutations in a number of genes (polygenic), often coupled with an environmental influence. Environmental factors include things like alcohol or drug use, maternal infections, and exposure to hazardous materials. These disorders tend to run in families, although a pattern of inheritance is often difficult to identify.
  • 4. • Mitochondrial disorders. These disorders result from mutations in DNA found outside the cell nucleus in mitochondria. Mitochondria are structures that make energy for the cells. If there is a mitochondrial gene mutation, energy production is affected. The DNA in mitochondria is inherited only from the mother. • Chromosomal disorders. These disorders result when entire chromosomes or parts of chromosomes are missing or changed. Chromosomal disorders usually occur spontaneously, however, on rare occasions they are inherited. • Epigenetic disorders. These are disorders related to changes in the activity of genes, rather than a mutation in the structure of the DNA
  • 6. Classification of Single gene mutation (monogenic) A-Ion channels implicated in human epilepsy I. Autosomal dominant inheritance 1. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) 2. Benign familial neonatal convulsion (BFNC) 3. Generalized epilepsy with febrile seizures plus (GEFS+) 4. Juvenile myoclonic epilepsy (JME) 5. Autosomal dominant idiopathic generalized epilepsy
  • 7. Classification of Single gene mutation (monogenic) II. Sporadic 1. Severe myoclonic epilepsy of infancy III.Other ion channel gene implicated in epilepsy (mutation identified in small number of patients, so role in epilepsy less clear) 1. Episodic ataxia type 1 and type 2
  • 8. Classification of Single gene mutation (monogenic) • B- Single Non ion channel gene mutation implicated in epilepsy 1. Progressive myoclonic epilepsy (PME) 2. Autosomal dominant partial epilepsy with auditory features (ADPEAF) • C- single gene mutation with high risk of developing epilepsy
  • 9. Ion channels implicated in human epilepsy (AD) • 1-Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) • Feature:- characterized by childhood onset of clusters of sleep-related seizures with predominant motor and dystonic features. • Gene , locus and protein CHRNA4 20q13 Ach receptor α4 subunit CGRNB2 1q21 Ach receptor β2 subunit
  • 10. The neuronal nicotinic acetylcholine receptors (nAChRs) (CHRNA4/CHRNB2) are pentamers, with each subunit containing four transmembrane domains. At least ten nAChR subunits, which can assemble into heteromeric (α2–α6, β2–β4) or homomeric receptors ((α 7, (α 9), are expressed in the human brain. The binding of two agonist molecules is required for channel opening. The channel itself shows little selectivity among monovalent cations
  • 11. Ion channels implicated in human epilepsy (AD) • 2- Benign familial neonatal convulsion (BFNC) • Feature:- is a rare, highly penetrant, autosomal dominant disorder with short-lasting multifocal or generalized seizures beginning between a few days of life and three months of age. A few patients will manifest isolated seizures later in life. • locus , Gene , and protein • 20q13 KCNQ2 M-current potassium channel • 8q24 KCNQ3 M-current potassium channel
  • 12. Voltage-gated potassium channels (KCNQ2/KCNQ3) are tetramers made up from homologous subunits. Each subunit contains six transmembrane domains. The fourth transmembrane domain carries several positively charged amino acids, which cause a conformational change on membrane depolarization. The linker between transmembrane domains 5 and 6 contains the selectivity filter that lines the ion pore
  • 13. Ion channels implicated in human epilepsy (AD) • 3-Generalized epilepsy with febrile seizures plus (GEFS+) • Feature:- GEFS+ encompasses a spectrum of childhood-onset epilepsy phenotypes including FS and FS+ (when afebrile seizures occur and/or FS continue past age six years). Other less-common phenotypes are FS+ with absence, myoclonic or atonic seizures, partial epilepsies, myoclonic astatic epilepsy (MAE) and severe myoclonic epilepsy in infancy • locus , Gene , and protein • 2q24 SCN1A Voltage-gated sodium channel α1 subunit 19q13 SCN1B Voltage-gated sodium channel β1 subunit 2q23 SCN2A Voltage-gated sodium channel α2 subunit 5q31 GABRG2 GABAA receptor subunit (discuss in JME)
  • 14.
  • 15. Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the gating kinetics of the channel.
  • 16. Ion channels implicated in human epilepsy (AD) • 4-Juvenile myoclonic epilepsy (JME) • Feature:- Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years old. People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon awakening or shortly afterward. Half of patients with this condition have relatives with epilepsy. The genetic basis of this syndrome is complex and the mechanism of transmission is unclear. • locus , Gene , and protein • 5q34-q35 GABRA1 GABA A receptor a1 subunit
  • 17.
  • 18. The GABAA (γ-aminobutyric acid, subtype A) receptors (GABRG2/GABRA1) are ligand-gated ion channels that probably evolved from the same ancient genes as the nAChRs, with whom they share several features, such as four transmembrane domains per subunit and a pentameric structure. GABAA receptors are selective for small anions and allow both chloride and bicarbonate to permeate
  • 19. Ion channels implicated in human epilepsy (AD) 5- autosomal dominant idiopathic generalized epilepsy • locus , Gene , and protein • 3q26 CLCN2 Chloride channels
  • 20. Voltage-gated chloride channels of the CLCN type comprise a gene family with nine mammalian members. They build homodimeric proteins, which probably contain two separate pores. CLCN channels conduct chloride ions across cell membranes, governing the electrical activity of cells.
  • 21. Ion channels implicated in human epilepsy (sporadic) 1. Severe myoclonic epilepsy of infancy (Dravet’s syndrome) • Feature:- Severe myoclonic epilepsy of infancy (SMEI) is an epileptic encephalopathy beginning in infancy with prolonged clonic febrile and afebrile seizures and is subsequently associated in most children with myoclonic, atypical absence and sometimes focal seizures Sporadic SMEI has been associated with de novo SCN1A mutations in 30% of patients • Gene , locus and protein SCN1A 2q24 Sodium channel subunit
  • 22.
  • 23. Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the gating kinetics of the channel.
  • 24.
  • 25. Other ion channel gene implicated in epilepsy (mutation identified in small number of patients, so role in epilepsy less clear) 1- Episodic ataxia type 1 and 2 (EA1,2) Gene , locus and protein In EA1 KCNA1 12p13 Potassium channel subunit In EA2 CACNA1A 19p13 Calcium channel subunit
  • 26. Single Non ion channel gene mutation implicated in epilepsy 1-Progressive myoclonus epilepsies (PMEs) • The progressive myoclonus epilepsies (PMEs) are a group of rare disorders in which there is progressive neurological deterioration together with myoclonus (twitching) and epilepsy. Several PMEs have autosomal recessive inheritance, including: A- AD as 1. dentatorubral-pallidoluysian atrophy (DRPLA), B- AR as 1. Unverricht-Lundborg disease 2. Sialidosis or cherry-red spot myoclonus 3. Lafora’s disease 4. Neuronal ceroid lipofuscinosis (NCL or Batten’s disease)
  • 27. phenotype Mood of inheritance feature gene locus protein dentatorubral- pallidoluysian atrophy AD appears before age 30; affected people have muscle twitches, epilepsy, dementia, ataxia , and choreoathetosis CAG expansion in a gene on 12p13.31 Unverricht- Lundborg disease AR Usually presents in childhood with stimulus sensitive and spontaneous myoclonus, tonic- clonic seizures, ataxia, and mild cognitive decline cystatin B gene 21q22.3 protease inhibitor Sialidosis or cherry- red spot myoclonus AR Storage disese the sialidase gene on 6p21.3.
  • 28. phenotype Mood of inheritance feature gene locus protein Lafora’s disease AR Myoclonic epilepsy with onset in the second decade, associated with visual hallucinations and cognitive decline. The characteristic carbohydrate accumulations (Lafora bodies) EPM2A/ EPM2B 6q24 Laforin is a tyrosine phosphata se Neuronal ceroid lipofuscinosis (NCL or Batten’s disease) AR associated with early visual impairment, cognitive decline, and spasticity 1-palmitoyl-protein thioesterase gene (1p32), causing either infantile or juvenile-onset NCL 2- the tripeptidyl peptidase 1 gene (11q15) and associated with late infantile onset NCL 3- CLN3 gene on 16p associated with a juvenile-onset form
  • 29. Single Non ion channel gene mutation implicated in epilepsy 2-Autosomal dominant partial epilepsy with auditory features (ADPEAF) • Feature:- familial temporal lobe epilepsy (FTLE) includes mesial and lateral forms. The lateral FTLE [autosomal dominant partial epilepsy with auditory features (ADPEAF)] begins in childhood–adolescence with auditory hallucinations, alone or with other sensory (olfactory, vertiginous, visual) symptoms. Mesial FTLE has childhood onset and seizures have mesial temporal lobe auras, including de ´ja ` vu, perceptual changes or autonomic phenomena No loci have been found. • Gene , locus and protein ADPEAF 10q24 LGI1 Leucine-rich glioma inactivated 1 Functional inactivation of one allele led to ADPEAF, whereas silencing of both alleles was observed in several high-grade gliomas.
  • 30. LGI1 is secreted from the presynapse and binds to postsynaptic ADAM22. Binding to ADAM22 results in altered intracellular signalling in the postsynapse that decreases excitability, probably through subunit changes in postsynaptic glutamate receptors. Mutations in LGI resulting in lack of ADAM22-mediated signalling therefore result in a net increase in excitability.
  • 31. Epitempin repeat in epilepsy-associated genes. The proteins encoded by both LGI1, the gene involved in autosomal dominant lateral temporal lobe epilepsy, and the MASS1/VLGR1 gene, which is mutated in the Frings mouse model for audiogenic seizures and in one family with febrile seizures, share the epitempin repeat. The MASS1/VLGR1 protein — one of the largest membrane proteins and a member of the superfamily of seven-helix G-protein coupled receptors — contains six complete and one degenerate copy of the epitempin repeat. MASS1/VLGR1 is expressed in the developing nervous system rather than in the adult brain. Its overall structure shows homologies to large G protein coupled receptors from the flamingo family, the latrophilins and the brain angiogenesis inhibitors. These receptors are mainly involved in neuronal development. Furthermore, the leucine-rich repeat (LRR) domain subtype present in the LGI1 protein is also found in Slit, a neurogenic protein involved in axonal guidance. It is therefore tempting to speculate that both MASS1/VLGR1 and LGI1 cause epilepsy by interference with normal brain development. aa, amino acid residues; TM, transmembrane domain
  • 32. Other single gene disorders that can manifest as epilepsy • Tuberous sclerosis • Tuberous sclerosis (TS) is a frequent cause of malignant childhood epilepsy, in particular West syndrome (hypsarrhythmia, mental retardation, and infantile spasms). Approximately half of patients with TS are familial cases, and the other half are sporadic. TS is caused by dominant mutations of one or other of two tumour suppressor genes (TSC1 and TSC2 located on 9q34 and 16p13.3, respectively) Approximately 80% of people with tuberous sclerosis develop epilepsy • Neurofibromatosis 1 (NF-1) • Approximately 3% to 13% of people with NF-1 develop epilepsy, although with a far better prognosis than TS.
  • 33. . Fragile X syndrome Fragile X syndrome is caused by a gene mutation on the X chromosome. It causes mild to severe intellectual disability, and approximately 20% to 40% of people with the condition will also develop epilepsy. If a father has fragile X syndrome, he will pass a milder form of the disorder to his daughters but will not pass it to his sons. If a mother has fragile X syndrome, her children have a 50% chance of inheriting it. The gene is often passed down in a milder form, so that families may be unaware that they carry it.
  • 34.
  • 35. Rett syndrome Rett syndrome is caused, in most cases, by a newly discovered mutation on the X chromosome. In a few families, the syndrome is inherited in an X-linked dominant pattern. It was initially believed that Rett syndrome affects only girls; however, it has recently been found to occur rarely in boys as well. The disorder usually develops between one and two years of age. Children with the disorder have epilepsy in 70% to 80% of cases, together with other problems such as constant hand-wringing, difficulty walking, developmental disability and autism. Acute intermittent porphyria Acute intermittent porphyria is a rare disease caused by a gene mutation in the HMBS gene on chromosome 11, which controls a step in the production of hemoglobin. The symptoms of the condition consist of severe attacks of abdominal pain, vomiting, digestive problems, and seizures. The attacks are triggered by factors such as certain drugs, smoking, dieting, other illnesses, and stress.
  • 36.
  • 37. Leukodystrophies Leukodystrophies are disorders affecting the production or maintenance of the fatty covering of nerves. As a result, signals travel more slowly than normal through the nervous system. This disrupts the functioning of the nervous system, which can sometimes include seizures. Leukodystrophies can be caused by mutations in many different genes; their inheritance pattern depends on which gene is affected. In some cases, the mutation arises spontaneously. More than 30 leukodystrophies have been identified. Some specific leukodystrophies are Alexander disease, Canavan disease, and Krabbe disease.
  • 38. inherited metabolic conditions A number of inherited metabolic conditions may cause seizures, including: • aminoacidopathies such as phenylketonuria (PKU) and maple syrup urine disease • galactosemia • lysosomal lipid storage diseases such as Tay-Sachs disease • peroxisomal disorders • pseudohypoparathyroidism • pyridoxine dependency
  • 40. Multifactorial disorders • A number of epilepsy syndromes are thought to be multifactorial or complex disorders, in which genetic and environmental factors both seem to play a part. • Among epilepsies with complex inheritance, IGEs seem very suitable for genetic studies because they are common. BUT the unknown mode of inheritance, the heterogeneity of the epilepsy phenotypes, the uncertainty of the genetic overlapping of IGE sub-syndromes and the lack of large families are major obstacles to the study of the genetic architecture of IGE
  • 41. Myoclonic-astatic epilepsy Myoclonic-astatic epilepsy usually appears between two and five years of age, with a variety of seizure types. The relatives of affected children often have other forms of epilepsy or febrile seizures, suggesting a strong genetic component. It is possible that several different genes are involved, as well as other modifying factors. Benign epilepsy of childhood with centrotemporal spikes (BECTS) Benign epilepsy of childhood with centrotemporal spikes (BECTS), also known as benign rolandic epilepsy, is one of the most common childhood epilepsy syndromes. It usually begins between ages five and 10 years and disappears in adolescence. Benign myoclonic epilepsy of infancy Benign myoclonic epilepsy of infancy is a rare condition that usually affects children between six months and three years old. Children with the syndrome have brief myoclonicseizures that are usually easy to control with medication. In about 30% of cases, other family members also have some form of epilepsy or febrile convulsions.
  • 42. Juvenile myoclonic epilepsy Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years old. People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon awakening or shortly afterward. Half of patients with this condition have relatives with epilepsy. The genetic basis of this syndrome is complex and the mechanism of transmission is unclear. It is possible that several different genes are responsible. Childhood absence epilepsy Childhood absence epilepsy begins between four and 10 years old, and involves severe and frequent absence seizures. In up to 44% of cases, other family members also have epilepsy. Some researchers have found links to chromosome 1 or chromosome 8. However, it seems likely that other factors besides genetics are involved. Juvenile absence epilepsy Juvenile absence epilepsy is similar to childhood absence epilepsy, but usually begins later in life, between 10 and 17 years old. Some children with this syndrome have family members with epilepsy.
  • 44. Mitochondrial disorders • Myoclonus epilepsy and ragged-red fibres (MERRF) Myoclonus epilepsy and ragged-red fibres (MERRF) is a progressive myoclonus epilepsy that is caused by missense mutations in the mitochondrial gene coding for lysine tRNA. People with this syndrome manifest it in a wide variety of ways; some are unaffected, some develop epilepsy later in life, and others develop severe, progressive epilepsy with dementia as children. The mutation is passed from mother to child.
  • 46. Chromosomal disorders 1- Down syndrome Down syndrome is caused by an additional copy of chromosome 21. This means that instead of the normal pair of chromosomes, there are 3 copies. This is called a trisomy. Down syndrome is also referred to as Trisomy 21. A trisomy is caused by an error that occurs during cell division. Approximately 2% to 15% of people with Down syndrome develop epilepsy. • Other trisomies Other trisomies that can result in epilepsy in 20% to 25% of cases are trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and trisomy 22.
  • 47. 2- Wolf-Hirschhorn syndrome Wolf-Hirschhorn syndrome occurs when part of chromosome 4 is deleted. About 70% of people with this condition have epilepsy.
  • 48. 3- Angelman syndrome Angelman syndrome is caused by a deletion on one arm of the copy of chromosome 15 that came from the person’s mother. More than 80% of people with this condition develop seizures, usually by age three.
  • 49. 4- Ring chromosome abnormalities Ring chromosome abnormalities are rare disorders that occur when both ends of a chromosome are damaged and the chromosome reforms in a ring shape. Ring chromosome abnormalities, including ring chromosomes 6, 9, 14, 15, and 20, account for 2% to 3% of cases of epilepsy, although not all people with these conditions have seizures.